Passirani C, Barratt G, Devissaguet J P, Labarre D
Laboratoire de Physico-Chimie, Pharmacotechnie et Biopharmacie, URA CNRS 1218, Faculté de Pharmacie, Université Paris XI, Châtenay-Malabry, France.
Pharm Res. 1998 Jul;15(7):1046-50. doi: 10.1023/a:1011930127562.
In a biomimetic approach to the development of drug carriers escaping early capture by phagocytes, nanoparticles made of amphiphilic copolymers of either heparin or dextran and methyl methacrylate were evaluated relative to their in vivo blood circulation time. They were compared to bare PMMA nanoparticles.
Owing to the fluorescent properties of the covalently attached N-vinyl carbazole, the particles could be detected directly in mouse plasma. Samples were drawn at different time intervals and fluorescence was recorded.
After an initial phase of elimination from the blood with a half-life of 5 h, the remaining heparin nanoparticles circulated for more than 48 h and were still detectable in the plasma at 72 h. Dextran nanoparticles were also eliminated very slowly over 48 h. Bare poly (methyl methacrylate) nanoparticles were found to have a half-life of only 3 min.
Both types of nanoparticles proved to be long-circulating. The potent capacity for opsonisation of the poly(methyl methacrylate) core were hidden by the protective effect of either polysaccharide, probably due to a dense brush-like structure. In the case of heparin nanoparticles, the "stealth" effect was probably increased by its inhibiting properties against complement activation.
在一种仿生方法中开发能逃避吞噬细胞早期捕获的药物载体,对由肝素或葡聚糖与甲基丙烯酸甲酯的两亲共聚物制成的纳米颗粒的体内血液循环时间进行了评估。将它们与裸露的聚甲基丙烯酸甲酯纳米颗粒进行比较。
由于共价连接的N-乙烯基咔唑具有荧光特性,这些颗粒可以直接在小鼠血浆中检测到。在不同时间间隔采集样本并记录荧光。
在血液中最初的消除阶段半衰期为5小时后,剩余的肝素纳米颗粒循环超过48小时,在72小时时血浆中仍可检测到。葡聚糖纳米颗粒在48小时内也消除得非常缓慢。发现裸露的聚甲基丙烯酸甲酯纳米颗粒的半衰期仅为3分钟。
两种类型的纳米颗粒都被证明具有长循环特性。聚甲基丙烯酸甲酯核心的强大调理作用能力被任何一种多糖类的保护作用所掩盖,这可能是由于致密的刷状结构。就肝素纳米颗粒而言,其“隐形”效果可能因其对补体激活的抑制特性而增强。